Cite
HARVARD Citation
Frappaz, D. et al. (2016). Phase 1 study of dalotuzumab monotherapy and ridaforolimus–dalotuzumab combination therapy in paediatric patients with advanced solid tumours. European journal of cancer. pp. 9-17. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Frappaz, D. et al. (2016). Phase 1 study of dalotuzumab monotherapy and ridaforolimus–dalotuzumab combination therapy in paediatric patients with advanced solid tumours. European journal of cancer. pp. 9-17. [Online].